Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
15:46 | Apnimed sets sights on sleep apnoea pill approval following Phase III win | ||
13:46 | Novo Nordisk defeated in Wegovy patent dispute by Viatris | ||
13:46 | Kling Bio and Sanofi link for antibodies and epitopes discovery | ||
13:46 | How ICH E6 (R3) is changing clinical trials | ||
12:46 | Exploring AI-powered cell simulations and the launch of the world's first virtual lab | ||
11:46 | Janssen's Darzalex new indication gains EC approval for SMM | ||
Mi | UK enacts law to decentralise manufacture of personalised treatments | ||
Mi | AstraZeneca announces $50bn US investment plans by 2030 | ||
Mi | Sanofi to acquire Vicebio's share capital for $1.15bn upfront | ||
Di | J&J seeks FDA approval for icotrokinra to treat psoriasis | ||
Di | Sarepta halts Elevidys shipments following FDA pressure | ||
Di | Biogen to invest further $2bn in North Carolina's Research Triangle Park | ||
Mo | Life sciences VC Omega Funds closes $647m funding round | ||
Mo | Sarepta refuses to pull gene therapy despite FDA order | ||
Mo | Five considerations when scaling up mAbs in partnership with a CDMO | ||
Mo | CDMO insights podcast series: Our Experience is Your Strength | Episode #2 Gene Therapy Fill-Finish | ||
Mo | Sanofi concludes Blueprint Medicines acquisition | ||
Mo | Fangzhou and Novo Nordisk link on chronic disease management | ||
Fr | Astellas and KISED link to support Korean pharma startups | ||
Fr | ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing | ||
Fr | FDA approves GSK's prefilled syringe presentation of Shingrix | ||
Fr | Can rare disease research in the US thrive under the new administration? | ||
17.07. | Ten years of Rare Pediatric Disease Designation: impact on drug approvals | ||
17.07. | Sarepta Therapeutics to cut 500 jobs amid restructuring | ||
17.07. | Thermo Fisher acquires Sanofi's steriles manufacturing site in US |